Safety of salivary gland-administered replication-deficient recombinant adenovirus in rats

Delporte C, Miller G, Kagami H, Lillibridge CD, O'Connell BC, Atkinson JC, Baum BJ: Safety of salivary gland‐administered replication‐deficient recombinant adenovirus in rats. J Oral Pathol Med 1998; 27: 34–8. © Munksgaard, 1998. We have examined the safety of a replication‐deficient recombinan...

Full description

Saved in:
Bibliographic Details
Published inJournal of oral pathology & medicine Vol. 27; no. 1; pp. 34 - 38
Main Authors Delporte, Christine, Miller, Georgina, Kagami, Hideaki, Lillibridge, C. David, O'Connell, Brian C., Atkinson, Jane C., Baum, Bruce J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.01.1998
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Delporte C, Miller G, Kagami H, Lillibridge CD, O'Connell BC, Atkinson JC, Baum BJ: Safety of salivary gland‐administered replication‐deficient recombinant adenovirus in rats. J Oral Pathol Med 1998; 27: 34–8. © Munksgaard, 1998. We have examined the safety of a replication‐deficient recombinant adenovirus administered at a single, high dose intraductally to rat submandibular glands or systemically via the femoral vein. The virus used directed the synthesis of human aquaporin‐1, a water channel protein, and is termed AdhAQPl. Comparisons were made 1 and 9 days post‐infection with animals administered either a similar virus encoding no transgene or the viral suspension buffer. Animals were specifically not given anti‐inflammatory drugs to impede the well‐known immunopathologic response to recombinant adenoviral administration. Serum chemistries and hematological parameters were monitored. Rats were subjected to complete gross necropsy and selected tissues were evaluated by histopathology. Most clinical chemistry and hematology values were within normal ranges; however, evidence of inflammation (e.g., elevated lactic dehydrogenase, total leukocyte count) was seen. Gross pathology was normal, as was histopathology, excepting rare focal areas of necrosis. The results show that intrasalivary gland or intravenous AdhAQPl administration leads to low levels of toxicity in rats.
Bibliography:ark:/67375/WNG-RGFF16D2-C
ArticleID:JOP34
istex:A71E4439AD0943063AA80EAE4B387C13FD45342D
GTTB, NIDR, NIH, 10 Center Drive, MSC 1190, Bldg. 10, Room 1N113, Bethesda, MD 20892, USA
ISSN:0904-2512
1600-0714
DOI:10.1111/j.1600-0714.1998.tb02088.x